SB939

SB-939 · S*BIO

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SB939, covering 2012-04-23 to 2023-08-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas [Phase 2]